The correlation of crystalline and elemental composition of urinary stones with a history of bacterial infections: TXRF, XRPD and PCR-DGGE studies.


Journal

European biophysics journal : EBJ
ISSN: 1432-1017
Titre abrégé: Eur Biophys J
Pays: Germany
ID NLM: 8409413

Informations de publication

Date de publication:
Jan 2019
Historique:
received: 28 02 2018
accepted: 19 11 2018
revised: 27 08 2018
pubmed: 30 11 2018
medline: 5 2 2019
entrez: 29 11 2018
Statut: ppublish

Résumé

The aim of this study was to analyze the correlation between past bacterial infections and the type and chemical composition of urinary stones experienced by human patients. Bacteria have been recognized to contribute to urinary stones; however, the role of uropathogens in the development of specific stones has not been extensively investigated. The detection of past bacterial infection (eleven different bacterial species) in urinary stones from 83 patients was made on a DNA level using polymerase chain reaction (PCR) and denaturing gradient gel electrophoresis (DGGE) and correlated with the chemical composition of urinary stones measured using X-ray powder diffraction (XPRD) technique and their elemental composition by total reflection X-ray fluorescence (TXRF). In this study, two scenarios of urinary stones formation mediated by Proteus sp. or Escherichia coli are presented. The first one is associated with Proteus spp. which dominated in 84% of infectious urinary stones and is strongly correlated with struvite and calcium phosphate, in whose matrix additionally strontium, phosphorus, potassium, nickel and zinc are detected. The formation of these stones is closely correlated with urease activity. The second scenario for urinary stone mineralization is associated with E. coli identified in weddellite stones, in which matrix iron was detected. In conclusion, the statistical correlations of bacterial infections with crystalline and elemental composition showed that in mixed bacterial infections, one scenario dominated and excluded the second one.

Identifiants

pubmed: 30483831
doi: 10.1007/s00249-018-1338-7
pii: 10.1007/s00249-018-1338-7
pmc: PMC6330562
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

111-118

Subventions

Organisme : European Regional Development Fund
ID : POPW.01.01.00-26-013/09-04

Références

Clin Microbiol Rev. 2000 Oct;13(4):534-46
pubmed: 11023955
Kidney Int. 2002 May;61(5):1821-9
pubmed: 11967033
Dis Mon. 2003 Feb;49(2):71-82
pubmed: 12601338
Infect Immun. 2004 May;72(5):2922-38
pubmed: 15102805
J Clin Microbiol. 2004 Aug;42(8):3549-57
pubmed: 15297496
Infect Immun. 2004 Sep;72(9):5159-67
pubmed: 15322010
Clin Infect Dis. 2005 Jan 15;40(2):251-7
pubmed: 15655743
Int J Antimicrob Agents. 2006 Aug;28 Suppl 1:S91-107
pubmed: 16829052
J Microbiol Immunol Infect. 2006 Aug;39(4):328-34
pubmed: 16926980
Mikrobiyol Bul. 2008 Apr;42(2):245-54
pubmed: 18697422
Infect Immun. 2009 Mar;77(3):1155-64
pubmed: 19103764
J Endourol. 2009 Jun;23(6):1015-9
pubmed: 19496725
Med Arh. 2009;63(3):128-32
pubmed: 20088156
Microbiol Res. 2014 Jul-Aug;169(7-8):579-84
pubmed: 24239192
PLoS One. 2015 Oct 08;10(10):e0139575
pubmed: 26448465
Microbiol Spectr. 2015 Oct;3(5):null
pubmed: 26542036
J Food Sci Technol. 2016 Jan;53(1):42-9
pubmed: 26787931
Infect Dis Clin North Am. 2016 Dec;30(4):869-885
pubmed: 27816141
World J Urol. 2017 Sep;35(9):1395-1399
pubmed: 28303335
Urol Clin North Am. 2017 Aug;44(3):355-366
pubmed: 28716317
Microbiol Rev. 1995 Sep;59(3):451-80
pubmed: 7565414
Gastroenterology. 1995 Mar;108(3):860-4
pubmed: 7875489
Clin Chem. 1998 Mar;44(3):586-90
pubmed: 9510866
Nephron. 1999;81 Suppl 1:50-9
pubmed: 9873215

Auteurs

Michał Arabski (M)

Department of Biochemistry and Genetics, Institute of Biology, Jan Kochanowski University, Świętokrzyska St. 15, 25-406, Kielce, Poland. arabski@ujk.edu.pl.

Ilona Stabrawa (I)

Institute of Physics, Jan Kochanowski University, Świętokrzyska St. 15, 25-406, Kielce, Poland.
Holycross Cancer Center, Artwińskiego St. 3, 25-734, Kielce, Poland.

Aldona Kubala-Kukuś (A)

Institute of Physics, Jan Kochanowski University, Świętokrzyska St. 15, 25-406, Kielce, Poland.
Holycross Cancer Center, Artwińskiego St. 3, 25-734, Kielce, Poland.

Katarzyna Gałczyńska (K)

Department of Biochemistry and Genetics, Institute of Biology, Jan Kochanowski University, Świętokrzyska St. 15, 25-406, Kielce, Poland.

Dariusz Banaś (D)

Institute of Physics, Jan Kochanowski University, Świętokrzyska St. 15, 25-406, Kielce, Poland.
Holycross Cancer Center, Artwińskiego St. 3, 25-734, Kielce, Poland.

Łukasz Piskorz (Ł)

St. John's God Hospital, Kosynierów Gdyńskich St. 61, 93-357, Łódź, Poland.

Ewa Forma (E)

Department of Cytobiochemistry, Faculty of Biology and Environmental Protection, University of Lodz, Pomorska St. 141/143, 90-236, Łódź, Poland.

Magdalena Bryś (M)

Department of Cytobiochemistry, Faculty of Biology and Environmental Protection, University of Lodz, Pomorska St. 141/143, 90-236, Łódź, Poland.

Waldemar Różański (W)

2nd Department of Urology, Medical University of Lodz, Pabianicka St. 62, 93-513, Łódź, Poland.

Marek Lipiński (M)

2nd Department of Urology, Medical University of Lodz, Pabianicka St. 62, 93-513, Łódź, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH